| ORIGINAL ARTICLE |
|
| Year : 2005 | Volume
: 53
| Issue : 2 | Page : 101-104 |
|
|
Role of Photodynamic Therapy in Polypoidal Choroidal Vasculopathy
Nazimul Hussain1, Anjli Hussain1, Sundaram Natarajan2
1 L. V. Prasad Eye Institute, Hyderabad, India
2 Aditya Jyot Eye Hospital, Mumbai, India
Correspondence Address:
Nazimul Hussain
Smt. Kanuri Santhamma Retina Vitreous Centre, L. V. Prasad Eye Institute, L. V. Prasad Marg, Banjara Hills, Hyderabad - 500 034
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0301-4738.16172
|
|
|
Purpose: To evaluate photodynamic Therapy (PDT) with Verteporfin for polypoidal choroidal vasculopathy (PCV) involving the fovea in Indian eyes, through a retrospective interventional case series.
Materials and Methods: We retrospectively reviewed the records of 9 patients (9 eyes) diagnosed to have PCV with foveal involvement between September 2001 and October 2002.
Results: Nine eyes underwent PDT for PCV. Follow-up ranged from 12 to 16 months. Initial visual acuity (VA) ranged from 1/60 to 6/12 and final VA varied from 1/60 to 6/9 at the end of follow- up. VA improved in 4/9 eyes (44.4%) by one line and remained unchanged in 5/9 eyes (55.6%), hence it was considered stabilized in all eyes. No adverse effects or events were observed during or after treatment with verteporfin.
Conclusion: PDT may be beneficial for PCV with foveal involvement. Its long-term efficacy requires to be evaluated |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
